Elicio Therapeutics Correlations

ELTX Stock   8.75  0.63  7.76%   
The current 90-days correlation between Elicio Therapeutics and Beyond Meat is 0.15 (i.e., Average diversification). The correlation of Elicio Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Elicio Therapeutics Correlation With Market

Significant diversification

The correlation between Elicio Therapeutics and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Elicio Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elicio Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Elicio Stock please use our How to Invest in Elicio Therapeutics guide.

Moving together with Elicio Stock

  0.71AZN AstraZeneca PLC ADRPairCorr
  0.64LLY Eli LillyPairCorr
  0.84PLX Protalix BiotherapeuticsPairCorr
  0.75SNY Sanofi ADRPairCorr
  0.71DRMAW Dermata TherapeuticsPairCorr
  0.69NVCT Nuvectis PharmaPairCorr
  0.73AMGN Amgen IncPairCorr

Moving against Elicio Stock

  0.88VINC Vincerx Pharma Earnings Call This WeekPairCorr
  0.79ZURA Zura Bio LimitedPairCorr
  0.72MLTX MoonLake ImmunotherapeutiPairCorr
  0.69INBX Inhibrx Symbol ChangePairCorr
  0.63ELVN Enliven TherapeuticsPairCorr
  0.62IMMX Immix BiopharmaPairCorr
  0.61MRK Merck CompanyPairCorr
  0.57CDIOW Cardio DiagnosticsPairCorr
  0.46IMRX Immuneering CorpPairCorr
  0.35GPCR Structure TherapeuticsPairCorr
  0.86CDIO Cardio DiagnosticsPairCorr
  0.8CRNX Crinetics PharmaceuticalsPairCorr
  0.72ATNF 180 Life SciencesPairCorr
  0.68CGEM Cullinan Oncology LLCPairCorr
  0.62ASMB Assembly Biosciences Earnings Call This WeekPairCorr
  0.61BIIB Biogen IncPairCorr
  0.58SCLX Scilex HoldingPairCorr
  0.54PYXS Pyxis OncologyPairCorr
  0.52PMVP Pmv PharmaceuticalsPairCorr
  0.5CNSP Cns Pharmaceuticals Earnings Call This WeekPairCorr
  0.44AVTE Aerovate TherapeuticsPairCorr
  0.43ADVM Adverum BiotechnologiesPairCorr
  0.38CELC Celcuity LLC Earnings Call TomorrowPairCorr
  0.34PHIO Phio Pharmaceuticals Corp Earnings Call This WeekPairCorr
  0.32CMND Clearmind Medicine CommonPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
BYNDPLAY
PINSWB
PLAYIAS
BYNDIAS
WBKHC
PINSIAS
  
High negative correlations   
PLAYWB
BYNDKHC
PLAYKHC
PINSPLAY
BYNDWB
IASKHC

Risk-Adjusted Indicators

There is a big difference between Elicio Stock performing well and Elicio Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Elicio Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Elicio Therapeutics Corporate Management

Joy SeymourVP AffairsProfile
Esther WelkowskySenior DevelopmentProfile
Peter DeMuthChief OfficerProfile
Michael DiVecchiaSenior ResourcesProfile
Megan FiloonSecretary CounselProfile
Brian PiekosChief OfficerProfile